Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Neptunus Bioengineering is a key manufacturing and development subsidiary of the Shenzhen Neptunus Bioengineering Group, a prominent player in the Chinese pharmaceutical industry. Based in Changzhou, Jiangsu Province, the company specializes in the production of chemical pharmaceuticals, traditional Chinese medicine (TCM), and health supplements. Its operations are characterized by a strong focus on cardiovascular health, particularly through the production of Ginkgo biloba-based products and other nutritional supplements. The company maintains modern GMP-certified facilities to support its diverse portfolio of prescription and over-the-counter medications. As part of the larger Neptunus network, it contributes to the group's integrated value chain spanning R&D, manufacturing, and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changzhou Neptunus Bioengineering.